Thalipeace 50 Capsule belongs to the class of medications called immunomodulatory agents. It consists of the active ingredient Thalidomide. It is primarily indicated to treat patients recently diagnosed with multiple myeloma. Multiple myeloma is a type of cancer mainly affecting certain white blood cells called the plasma cell. These cells grow uncontrolled and accumulate in the bone marrow, damaging the bones and kidneys. It is also prescribed for treating moderate to severe new lesions in leprosy. Leprosy is a chronic disease that affects the skin and nerves and is caused by a bacteria called Mycobacterium leprae. 

The common side effects that are likely to be associated with Thalipeace 50 Capsule are sleepiness, headache, dizziness, rashes, pain, tiredness, constipation, nausea, impotence, loss of appetite, fever, depression, etc. Inform your doctor if these side effects disturb or persist in you.

Inform your medical professional if you are allergic to Thalipeace 50 Capsule and its ingredients. Inform your doctor if you have blood clots, heart attack, neuropathy (pain in the hands or feet caused by nerve damage), slow heart rate, low and high blood pressure,  liver or kidney problems, viral infections like HIV, hepatitis B virus, and varicella zoster. Your physician will monitor the thyroid function before and during treatment with this medication. Stop taking Thalipeace 50 Capsule and consult a doctor immediately if you have to think you are pregnant, if you have irregular periods, missed a period, have any change in menstrual bleeding, or if you had sex without using effective birth control. It is not recommended for adolescents and children under 18 years of age.

Adjunct to Dexamethasone for treating newly diagnosed multiple myeloma.

• Treatment of moderate to severe leprosy.

• Prevention of recurrence of skin lesions in leprosy.

Thalipeace 50 Capsule reduces inflammation and regulates the immune system. It works by enabling the body’s immune system and attacking the cancer cells. It stops the development of cancer cells by inhibiting the growth of blood vessels in tumors. It also modifies the production and activity of cytokines (growth factors) that are involved in the growth and metabolism of cancer cells.

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products that you are taking or have taken before the treatment. Certain medications may interact with Thalitero  50mg capsule and cause undesirable side effects. 

• Store below  25°C.

• Protect from light and moisture.

• Keep this medicine out of reach of children.

Take the capsule as a single dose at bedtime. Swallow the capsule whole with water. Avoid crushing or chewing the capsule. Wash your skin carefully with soap and water in case of contact with a broken capsule. 

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. 

Serious

• Nerve damage

• Decreased blood pressure

• Low WBC count

• Slow heartbeat

• Serious allergic reactions

• Tumor lysis syndrome

• Sudden pain in the chest or difficulty breathing

• Pain and swelling of legs

• Bleeding or bruising without injury

Common

• Sleepiness

• Rashes

• Headache

• Dizziness

• Impotence

• Decreased energy or strength

• Pain

• Tiredness

• Low calcium and blood count levels

• Swelling of hands and feet

• Constipation

• Numbness or tingling

• Nausea and reduced appetite

• Anxiety, depression, confusion, and mood swings

• Fever

• Weight loss or weight gain

• Indigestion, vomiting

• dry mouth

• Muscle cramps

• Blurred vision

• Chest infection, lung disease

• Ear problems

• Kidney damage.

• Women who are pregnant or suspect pregnancy should not use Thalipeace 50 Capsule.

• Use effective birth control for at least 4 weeks before starting treatment, during treatment, and for at least 4 weeks after stopping it.

• Handle the medication with disposable gloves to avoid skin contact.

• Do not donate blood or sperm during treatment and for at least 7 days after completing the treatment.